Rench Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.49M Sell
8,984
-174
-2% -$69.4K 0.94% 34
2026
Q2
$3.54M Sell
9,158
-112
-1% -$41.5K 0.95% 36
2026
Q1
$2.71M Sell
9,270
-741
-7% -$244K 0.82% 38
2025
Q4
$3.51M Sell
10,011
-788
-7% -$266K 1.01% 36
2025
Q3
$3.49M Buy
10,799
+4
+0% +$1.24K 1.02% 36
2025
Q2
$4.2M Buy
10,795
+668
+7% +$269K 1.33% 32
2025
Q1
$4.4M Buy
10,127
+204
+2% +$81.9K 1.52% 31
2024
Q4
$3.66M Sell
9,923
-628
-6% -$263K 1.25% 35
2024
Q3
$5.49M Buy
10,551
+793
+8% +$424K 1.88% 24
2024
Q2
$5.29M Buy
9,758
+347
+4% +$183K 1.9% 21
2024
Q1
$4.88M Buy
+9,411
New +$4.68M 1.87% 20

Other funds holding ELV

Rench Wealth Management's ELV Position: Q3 2026 in Review

Rench Wealth Management reduced its Elevance Health (ELV) stake by 1.9% in Q3 2026, selling an estimated $69.4K and leaving 8,984 shares worth $3.49M. The position accounts for 0.94% of the portfolio, ranked #34.

Rench Wealth Management first reported a position in ELV in Q1 2024 and has held it in 11 quarters since. The position peaked at $5.49M in Q3 2024. 1,621 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Rench Wealth Management held 8,984 shares of Elevance Health worth $3.49M as of Q3 2026.
  • Rench Wealth Management sold 174 Elevance Health shares in Q3 2026, an estimated $69.4K.
  • Elevance Health made up 0.94% of Rench Wealth Management's portfolio in Q3 2026, its #34 holding.
  • Rench Wealth Management first reported a position in Elevance Health in Q1 2024 and has held it in 11 quarters since.
  • Rench Wealth Management's Elevance Health position peaked at $5.49M in Q3 2024.
  • 1,621 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Rench Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.